FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics
The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal.
You may also be interested in...
Medical device recalls have ticked up this year because of defects in manufacturing, according to a report from Sedgwick.
The VALID Act, which will hand diagnostics oversight to the US FDA, has been reintroduced in the House of Representatives after it failed twice last year in Congress.
AdvaMed’s Medical Innovation Agenda for the 118th Congress emphasizes increased access to medical devices, from reimbursement for breakthrough devices to boosting America’s start-ups to closing the care disparities for underserved communities.